Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 451, 21-22 (3 January 2008) | doi:10.1038/451021a; Published online 2 January 2008
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
- More Challenges
- Powered by:
nature jobs
Research Fellows in Pluripotent Stem Cell Technology
- The University of Nottingham
- Nottingham, UK
Canada Excellence Research Chair in Biofuels and Biorefining Innovation
- University of British Columbia
- Vancouver, British Columbia Canada
Down's syndrome: Paradox of a tumour repressor
David W. Threadgill1
Abstract
Having three copies of chromosome 21 reduces the incidence of solid tumours in people with Down's syndrome. Studies in mice provide clues to why, and highlight a complex gene–function relationship.
Correlative epidemiological studies are powerful analytical tools that can provide insight into human health and disease. A case in point is the proposition1 that the age-adjusted incidence of solid tumours is lower in individuals with Down's syndrome than in the general population.
- David W. Threadgill is in the Department of Genetics, University of North Carolina at Chapel Hill, North Carolina 27599, USA.
Email: dwt@med.unc.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transferNature Immunology Article (01 Oct 2001)
Is the nitric oxide system involved in genetic hypertension in Dahl rats?Kidney International Original Article
A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteinsNature Immunology Article (01 Jun 2001)
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo ? use of the human tyrosinase promoter with human enhancersCancer Gene Therapy Original Article
See all 8 matches for Research